Advertisement

Implantable Cardioverter-Defibrillator therapy for primary prevention of sudden cardiac death in patients with severe Chagas cardiomyopathy

  • Augusto Cardinalli-Neto
    Affiliations
    Hospital de Base, São José do Rio Preto Medical School, Department of Cardiology and Cardiovascular Surgery, São José do Rio Preto city, SP, Brazil
    Search for articles by this author
  • Marcelo A. Nakazone
    Affiliations
    Hospital de Base, São José do Rio Preto Medical School, Department of Cardiology and Cardiovascular Surgery, São José do Rio Preto city, SP, Brazil
    Search for articles by this author
  • Luciano V. Grassi
    Affiliations
    Hospital de Base, São José do Rio Preto Medical School, Department of Cardiology and Cardiovascular Surgery, São José do Rio Preto city, SP, Brazil
    Search for articles by this author
  • Bruno G. Tavares
    Affiliations
    Hospital de Base, São José do Rio Preto Medical School, Department of Cardiology and Cardiovascular Surgery, São José do Rio Preto city, SP, Brazil
    Search for articles by this author
  • Reinaldo B. Bestetti
    Correspondence
    Corresponding author at: Hospital de Base, Department of Cardiology and Cardiovascular Surgery, Setor de Eletrocardiografia, Avenue Brigadeiro Faria Lima 5544, São José do Rio Preto city, SP, Brazil. Zip Code: 15090–000. Tel./fax: +55 17 3201 5065.
    Affiliations
    Hospital de Base, São José do Rio Preto Medical School, Department of Cardiology and Cardiovascular Surgery, São José do Rio Preto city, SP, Brazil
    Search for articles by this author
      Sudden cardiac death (SCD) affects about half of patients who died of Chagas disease followed at a referral center, and may victim up to 20% of patients without any evidence of heart disease [
      • Bestetti R.B.
      • Cardinalli-Neto A.
      Sudden cardiac death in Chagas' heart disease in the contemporary era.
      ]. In the vast majority of cases, SCD is caused by either sustained ventricular tachycardia (VT) degenerating into ventricular fibrillation (VF) or direct VF [
      • Bestetti R.B.
      • Cardinalli-Neto A.
      Sudden cardiac death in Chagas' heart disease in the contemporary era.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bestetti R.B.
        • Cardinalli-Neto A.
        Sudden cardiac death in Chagas' heart disease in the contemporary era.
        Int J Cardiol. 2008; 131: 9-17
        • Epstein A.E.
        • Dimarco J.P.
        • Ellenbogen K.A.
        • et al.
        ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.
        Heart Rhythm. 2008; 5: e1-e62
        • Verma A.
        • Sarak B.
        • Kaplan A.J.
        • et al.
        Predictors of appropriate Implantable Cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy.
        Pacing Clin Electrophysiol. 2010; 33: 320-329
        • Cardinalli-Neto A.
        • Bestetti R.B.
        • Cordeiro J.A.
        • Rodrigues V.C.
        Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving Implantable Cardioverter defibrillator therapy.
        J Cardiovasc Electrophysiol. 2007; 18: 1236-1240
        • Cardinalli-Neto A.
        • Greco O.T.
        • Bestetti R.B.
        Automatic Implantable Cardioverter-defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias.
        Pacing Clin Electrophysiol. 2006; 29: 467-470
        • Martinelli Filho M.
        • De Siqueira S.F.
        • Moreira H.
        • et al.
        Probability of occurrence of life-threatening ventricular arrhythmias in Chagas' disease versus non-Chagas' disease.
        Pacing Clin Electrophysiol. 2000; 23: 1944-1946
        • Borleffs C.J.
        • van Welsenes G.H.
        • van Bommel R.J.
        • et al.
        Mortality risk score in primary prevention Implantable Cardioverter Defibrillator recipients with non-ischemic or ischemic heart disease.
        Eur Heart J. 2010; 31: 712-718
        • Rossi M.A.
        • Ramos S.G.
        • Bestetti R.B.
        Chagas' heart disease: clinical-pathological correlation.
        Front Biosci. 2003; 8: e94-e109
        • Bestetti R.B.
        • Coutinho-Netto J.
        • Staibano L.
        • Pinto L.Z.
        • Muccillo G.
        • Oliveira J.S.M.
        Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas' disease.
        Cardiology. 1995; 86: 202-206
        • Rabinovich R.
        • Muratore C.
        • Iglesias R.
        • et al.
        Time to first shock in Implantable Cardioverter Defibrillator (ICD) patients with Chagas cardiomyopathy.
        Pacing Clin Electrophysiol. 1999; 22: 202-205
        • Bestetti R.B.
        • Theodoropoulos T.A.
        • Cardinalli-Neto A.
        • et al.
        Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
        Am Heart J. 2008; 156: 422-430
        • Shewan L.G.
        • Coats A.J.
        Ethics in the authorship and publishing of scientific articles.
        Int J Cardiol. 2010; 144: 1-2